« Novel Biosensor Detects A... | Main | Biotech Receives 18% of A... »

Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs

Filed in archive Biotech Hubs and Facilities , Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on March 22, 2007

GlaxoSmithKline PLC had invested S$20 million (US$13 million; €9.8 million) in a new laboratory in Singapore's biotechnology hub, Biopolis, as part of its Center for Research in Cognitive and Neurodegenerative Disorders, which focuses on discovering drugs to help cure Alzheimer's disease and schizophrenia links

"This new investment in GSK's research and development facility will enhance our drug discovery capabilities in Singapore. Our goal is to identify a clinical development candidate by the end of 2007 and we are on track to achieving that," director Paul Chapman was quoted as saying in a statement.

The new laboratory opened Tuesday.

Source: International Herald Tribune

Permalink: Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs
Tags: biotech investment biotech+investment cognitive+disorder alzheimer schizophrenia drug+discovery drug

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/59223

Bookmark this entry:

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Related Entries:

Microbia Collaborates with A*Star - 26 July 2005

SAP Software Founder Dietmar Hopp Invests On Biotechnology - 28 July 2006

Top Biotech Hubs for 2007 - 26 February 2007

Fruit Fly Offers Clues in Development of New Human Vaccines - 13 March 2007

Biotech Receives 18% of Angel Investments in 2006 - 22 March 2007

Biotech Showed Robust Growth in 2006 - 17 April 2007

Roche Invests $387 million in Biotech Drug Research - 28 January 2008

Vote for Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs:

Currently 7.00/10
1
2
3
4
5
6
7
8
9
10

Rating: 7.00 out of 4 vote(s) cast.

RSS	\| See all blog subscribe options
Google	\| What is RSS?
Yahoo!
Addthis
Bloglines
Newsletter
Grouptivity

Use the search to look for other interesting posts

Contributors (Last 90 days)
Ruth Schaffer (22)
This site has 1274 entries and is powered by Creative Weblogging since July 2005.
Do you want to start or edit an existing blog for us and get paid? More info.
Do you want to advertise on this blog? We have great ideas!
Do you have tips for us? Send them!

Advertise with us
Learn more about our advertising options or email advertising - at - creative-weblogging.com or give us a call at +1 (650) 331 4900.

Testimonials
'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'

Other blogs in the same channel in the Creative Weblogging Network

Health & Life Sciences
Allergies

Daily Power Walk

Daily Diabetic

Straightfromthedoc

Well Woman Blog

Disclaimer
Some of the contents of this site are protected Creative Weblogging Inc. 2004-2009.

Add your response to Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs:
Name: *	Email: (will never be shown)*	URL:

(* marked fields are required)
Notify me if more comments appear?	Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).	Remember me
Security Code: * (Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)


We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Tell a friend about Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs
Recipient email:*	Your email:*

(* Both email addresses are required for sending this article. They will never be shown or used for any marketing purposes)
Please enter a message which will be shown together with the article:

Security Code: (Please help us to sort out spam.)

Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs

Filed in archive Biotech Hubs and Facilities , Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on March 22, 2007

Bookmark this entry:

Related Entries:

Vote for Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs:

Add your response to Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs:

Tell a friend about Glaxo Invests S$20 Million in Biopolis to Discover Alzheimer and Schizophrenia Drugs

Categories

Archives

Our Editors recommend

Contributors (Last 90 days)

Advertise with us

Most popular

Testimonials

Recent Comments

Other blogs in the same channel in the Creative Weblogging Network

Health & Life Sciences

Disclaimer

Find other popular posts from our other blogs:

Daily Diabetic

Daily Power Walk

Well Woman Blog

Allergies

Straightfromthedoc

Supplychainer